Ectopic Adiposity and Coronary Atherosclerosis
to measure the CAC score, followed by CTA. We calculated CAC scores using dedicated software (Smartscore, version 3.5; GE Healthcare). 18 During an inspiratory breath hold, contrastenhanced scanning was performed by a retrospective ECGgated scan using the helical mode or prospective ECG-triggered CTA (with the center of the imaging window corresponding to 75% of the R-R interval) based on our previous report. 19, 20 A body weight-adjusted volume (0.6 ml/kg) of iodine-based contrast medium was injected into the antecubital vein over the course of 10s, followed by a 25-ml 0.9% NaCl solution flush over 5s. Reconstructed images were transferred to a computer workstation (Advantage Workstation Ver.4.4; GE Healthcare) for post-processing and subsequent image analysis.
Measurement of VAT Area and EAT Volume on CT
Abdominal scans were performed simultaneously at the level of the 4th and 5th lumbar vertebrae in the spiral position, and 12 slices of 5-mm thickness were obtained during a breath hold after normal expiration. The VAT area was defined as the intraperitoneal adipose tissue area with a CT density between −150 and −50 Hounsfield units (HU) on a slice at the level of the umbilicus, which was measured using dedicated software (Virtual Place, AZE Inc, Tokyo, Japan). 18, 21 EAT was defined as that seen surrounding the myocardium but limited by the epicardium on plain CT images acquired for calcium scoring. The EAT area was defined that with a density between −250 and −30 HU, which was manually traced and automatically quantified using the same software as for the lation, and 13 with missing data concerning 1 or more of the traditional CAD risk factors. Consequently, the data of 352 patients were analyzed. The Ethics Committee of Hiroshima University Hospital gave approval for the conduct of the study.
Risk Factor Assessments
Hypertension was defined as a systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or active treatment with an antihypertensive agent. Hypercholesterolemia was defined as a serum low-density lipoprotein (LDL) level ≥140 mg/dl on direct measurement, a total cholesterol ≥220 mg/dl, or current use of lipid-lowering drugs. Diabetes mellitus was defined by a glycosylated hemoglobin level ≥6.5%, 14 or current use of oral hypoglycemic drugs or insulin. Current smoking was defined as smoking regularly or having quit in the past 30 days. Metabolic syndrome (MetS) was diagnosed according to the Japanese criteria 15 and the Framingham risk score was calculated. 16 Obesity was defined as a body mass index (BMI) ≥25 kg/m 2 . 17
CT Angiography and Image Analysis
Imaging examinations were performed using a 64-slice CT scanner (LightSpeed VCT; GE Healthcare, Little Chalfont, Buckinghamshire, UK). Patients with a resting heart rate ≥60 beats/min were administered metoprolol 20-40 mg orally 60 min before the scan. All patients were administered nitroglycerin 0.3 mg sublingually just before scanning. An unenhanced scan with prospective ECG triggering was performed 
Results

Patients Characteristics and CT Findings
The mean age of the analyzed cohort was 61±11 years; 57% were male. More than half had hypertension (53%), the same proportion had hypercholesterolemia (53%), 18% had been VAT area. As previously described, 22 EAT volume was measured by calculating the sum of the EAT areas measured from 1 cm above the left main coronary artery to the left ventricular apex at 1-cm intervals.
Evaluation of CCTA Findings
We defined NCP as a structure >1 mm 2 in an area with a CT density ≤130 HU, located within the vessel wall and clearly distinguishable from the contrast-enhanced coronary lumen and surrounding pericardial tissue. 19,20 Independent observers assessed the presence of NCPs on cross-sectional and multiplanar CCTA image reconstructions in all coronary segments >2 mm in diameter according to the Society of Cardiovascular Computed Tomography 18-segment model. 23 The proportion of lumen stenosis was determined by measuring the luminal diameter at the narrowest site and comparing it with the diameter of the normal proximal site: ≥50% stenosis was considered clinically significant. Plaque volume was calculated by summating all the contiguous cross-sectional plaque areas along a vessel centerline using a slice thickness of 1.0 mm. 24
Statistical Analysis
Continuous variables are presented as mean ± standard deviation, and categorical variables are presented as numbers of patients (proportion). We compared the characteristics and CT findings of the patients allocated to 1 of 4 groups on the basis of CTbased EAT volume and VAT area measurements using the median value for each sex. Analysis of variance or the Kruskal- Table 2 shows the characteristics and CT findings of the 4 patient groups classified by VAT area and EAT volume according to the median VAT area (men, 102 cm 2 ; women, 69 cm 2 ) and the median EAT volume (men, 119 ml; women, 114 ml). Most of patient characteristics were significantly different among the 4 groups. Furthermore, the prevalence of NCPs, total plaque volume, and maximum proportion of luminal stenosis were significantly higher in the high EAT volume/low VAT group and the 2 high VAT groups compared with the low EAT volume/low VAT reference group.
Association of VAT Area and EAT Volume With the Presence of NCPs
ORs for the Presence of NCPs Stratified by EAT Volume and Other Adipose Factors
Univariate and multivariate ORs for the presence of NCPs were significantly increased in all the high EAT volume groups, whether also defined by VAT or MetS, when compared with the low EAT reference groups ( 2 ), respectively, and the median EAT volumes were 119 ml (IQR: 91-150 ml) and 114 ml (IQR: 82-148 ml), respectively. The VAT area and EAT volume had moderate correlations with BMI (R=0.66 and R=0.44, respectively; both P<0.001), and VAT area and EAT volume also moderately correlated with each other (R=0.51, P<0.001; Figure 1 ). 
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Data are presented as mean±standard deviation or number (%). *P<0.05 compared with the low VAT area low EAT volume reference group. Abbreviations as in Table 1 . TSUSHIMA H et al. detected by CCTA in patients with a CAC score of zero, suggesting that both high VAT area and high EAT volume are implicated in the pathophysiology of NCP formation. Consequently, we believe that combined assessment of VAT area and EAT volume may be a useful means of more accurately stratifying cardiac risk in this group of patients. Notably, an increased EAT volume identified patients with NCPs even when the VAT area was low, implying that accumulation of EAT contributes to coronary plaque formation, even in patients without abdominal obesity. This relationship was observed whether or not obesity was stratified by the presence of MetS.
Association of VAT and EAT With Coronary Atherosclerosis
It is increasingly recognized that EAT is a risk factor for coronary atherosclerosis. 25 Nevertheless, there have been few studies that have examined the combined contributions of EAT and VAT. In most cases, BMI, presence of MetS, or waist circumference are used as a substitute for VAT area. We have also studied the association between EAT volume and the presence and characteristics of NCPs, and proposed that VAT and EAT may work synergistically to accelerate coronary atherosclerosis from within and from outside the vessel wall, respectively. 22 Additionally, the subjects of the studies of EAT are patients with suspected CAD and with various levels of coronary atherosclerosis risk. In the present study, we targeted patients with a CAC score of zero, which is regarded as a marker
Framingham risk score category, and serum levels of LDL cholesterol, HDL cholesterol and CRP. The ORs of the high VAT area/low EAT volume group and the high VAT area/high EAT volume group were 2.80 (95% CI: 1.25-6.35, P=0.01) and 2.68 (95% CI: 1.36-5.45, P=0.004), respectively. Interestingly, the OR of the low VAT area/high EAT volume group was similar (OR 3.02, 95% CI: 1.33-6.90, P=0.008; Figure 2A ). Broadly comparable findings were observed in the analysis stratified by MetS/EAT volume. Compared with the non-MetS/low EAT volume reference group, the ORs for the presence of NCPs in the non-MetS/high EAT volume group, the MetS/low EAT group, and the MetS/high EAT volume group were 2.47 (95% CI: 1.29-4.80, P=0.007), 2.81 (95% CI 1.10-7.09, P=0.03), and 2.20 (95% CI: 1.10-4.45, P=0.03), respectively ( Figure 2B) . In contrast, when obesity was defined by BMI, the only OR for the presence of NCPs that was significantly elevated compared with the low BMI/low EAT volume reference group was in the low BMI/high EAT volume group (2.42, 95% CI 1.26-4.71, P=0.008; Figure 2C ). Figure 3 shows a representative case of a patient with high EAT volume, low VAT area, and NCPs.
Discussion
We found an association between epicardial and visceral abdominal adipose tissue distribution and the presence of NCPs Figure 3 . Coronary computed tomography angiography images from a 45-yearold man with a coronary artery calcium score of zero. Epicardial adipose tissue volume was elevated (150 ml) (A-C) but abdominal visceral adipose tissue area was low (92 cm 2 ) (D). The multiplanar reconstructed image shows a non-obstructive atherosclerotic lesion with non-calcified plaque in the proximal portion of the left anterior descending artery (E,F; arrows). The total plaque volume was 143 mm 3 . TSUSHIMA H et al.
of VAT area and EAT volume may be a more accurate means of stratifying risk in patients with a CAC score of zero. Taken together, we judge that surveillance CCTA would be an effective strategy for managing long-term risk in those found to have higher VAT area and/or a higher EAT volume on initial screening.
In this study, we studied whether different measures of obesity are useful as a substitute for VAT area. ORs for the presence of NCPs in combination with EAT volume were similar between MetS and VAT. Therefore, MetS status could be used as a surrogate marker of VAT area to avoid unnecessary exposure to ionizing radiation. In contrast, the OR in the low BMI/ high EAT volume group was significantly higher, but the high BMI groups was not significantly different compared with the reference group. One reason to explain this difference is that many of the patients with low VAT area may be included in the high BMI group.
Study Limitations
This was a cross-sectional study in which cardiovascular mortality and morbidity were not assessed; rather, an alternate endpoint of the presence of plaques on CCTA was used. Nevertheless, our findings support those of recent longitudinal studies. We recently described the relationship between high EAT volume (>107 ml) and increased rates of coronary events, even in a subgroup of patients with CAC score <100, 34 and the results of a large population study support the hypothesis that high EAT volume promotes early atherosclerosis, as EAT volume is reportedly associated with progression of coronary artery calcification, especially in subjects with low CAC scores. 30 We elected to use the presence of NCPs as the dependent variable, but had too few data to undertake a meaningful analysis of other variables such as the presence of obstructive stenosis or the number or volume of plaques.
We are also unable to identify the precise mechanism by which VAT and EAT accumulation could contribute to coronary plaque formation. However, our observation that serum lipid and glycosylated hemoglobin levels were more elevated in the high VAT than low VAT groups, but did not differ between the low EAT groups ( Table 2 ) is worthy of further study. Interestingly, serum CRP levels were also higher in both the low VAT/high EAT group and the high VAT group when compared with the low VAT/low EAT reference group, suggesting that systemic inflammation may also play a role in the onset of coronary atherosclerosis, in addition to direct effects on the vascular wall.
Conclusions
In patients with a CAC score of zero, high EAT volume is associated with the presence of NCPs on CCTA, even in those with low VAT area. EAT volume is eligible as a marker to be evaluated in addition to VAT area in patients with a CAC score of zero. We propose that accumulation of EAT may contribute to coronary plaque formation in patients without abdominal obesity or MetS.
of low risk for CAD. 10,11 To our knowledge, no other reports have examined both VAT area and EAT volume in patients with a CAC score of zero. Konishi et al reported that accumulation of pericardial fat, rather than abdominal obesity, could be implicated in the early development of CAD in their study of subjects with suspected CAD. 26 Our data from patients with fewer CAD risk factors are consistent with the findings for various levels of coronary atherosclerosis.
Cutoff Levels of VAT Area
The importance of EAT volume even in the absence of abdominal visceral obesity (low VAT area) or MetS does not help to establish whether abdominal visceral adiposity is an independent risk factor for cardiovascular disease, although VAT area is a criterion for diagnosing MetS in Japanese patients. 15 According to our previous report, the cutoff levels of VAT area to identify coronary artery calcification were 116 cm 2 and 82 cm 2 in men and women, respectively. 18 Furthermore, our other report also showed that when median VAT areas of 126 cm 2 for men and 91 cm 2 for women were used as cutoffs to define high and low VAT area groups, high VAT area was significantly associated with NCP burden. 21 In the present study, we used median VAT areas of 102 cm 2 for men and 69 cm 2 as the cutoffs for the high and low groups.
NCPs With a CAC Score of Zero
A CAC score of zero indicates a low prevalence of CAD and subsequent cardiovascular events in both symptomatic and asymptomatic patients. 10, 11 However, in our cohort of patients with a CAC score of zero, the prevalence of NCPs was 29%. Previous studies have identified a prevalence of NCPs of 7-39% in patients with a CAC score of zero. 27-29 It is suggested that risk stratification using the combination of VAT area and EAT volume is useful for identifying CAD in patients with a CAC score of zero.
A recent population-based, prospective cohort study found that EAT is also associated with the progression of coronary artery calcification, especially in younger subjects (age <55 years) and those with an existing low CAC score (≤100), suggesting that EAT may drive early atherosclerosis. 30 The results of this study 30 support our previous findings that high EAT volume is associated with an increased likelihood of NCPs in patients with a CAC score of zero.
EAT Volume and Detection of Plaques in Patients Without Abdominal Obesity
We used CCTA to show that high EAT volume was associated with increased ORs for the presence of NCPs in non-obese patients, which is consistent with the findings of previous studies of patients with various levels of coronary atherosclerosis. Pericardial fat is reportedly more abundant in non-obese patients with coronary atherosclerosis compared with those without, 31 and Okada et al reported a significant correlation between EAT volume and the severity of CAD or plaque components in nonobese patients. 32 Detection of plaques is thought to be clinically important, even if the plaques are non-obstructive, as the presence of both obstructive and non-obstructive CAD on CCTA reportedly predicts a worse prognosis. 33 
Clinical Implications
Although a CAC score of zero indicates a low risk of CAD and future cardiovascular events, the existence of NCPs cannot be ignored. Our findings suggest that patients with high EAT volume are at greater risk of coronary atherosclerosis, even in the absence of abdominal obesity. A simultaneous assessment
